Cendakimab (RPC4046, ABT 308, CC-93538) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both IL-13Ralpha1 and IL-13Ralpha2 with IC50s of 352 pM and 631 pM by ELISA, respectively.
Reinheit:
>99.0%
CAS Nummer:
[2151032-62-9]
Target-Kategorie:
IL Receptor/Related
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten